Trials / Conditions / Acute Respiratory Viral Infection

Acute Respiratory Viral Infection

5 registered clinical trials studyying Acute Respiratory Viral Infection — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Study to Evaluate the Efficacy, Safety, and Tolerability of the Ingavirin Forte Capsules (Valenta Pharm JSC) a NCT07420985	Valenta Pharm JSC	Phase 2
Recruiting	Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of ARVI in Children Aged 3-12 Years NCT06715891	Materia Medica Holding	Phase 3
Completed	Study of Safety and Efficacy of the Drug Cycloferone in Patients with Acute Respiratory Viral Infection NCT06286254	POLYSAN Scientific & Technological Pharmaceutical Company	—
Completed	A Study to Investigate Acute Respiratory Virus Infections in Participants at High Risk for Severe Illness NCT05661604	Janssen Research & Development, LLC	—
Completed	Clinical Study of Efficacy and Safety of Raphamin in the Treatment of ARVI in Children 12-18 Years Old NCT04918771	Materia Medica Holding	Phase 3